3651 - 3700 of 8801 Results
Title
Year
-
OPENTitle: Putamen–midbrain functional connectivity is related to striatal dopamine transporter availability in patients with Lewy body diseasesJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 8Issue #:Start Page: 554End Page: 559Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2015.06.001Best OA location URL: https://www.sciencedirect.com/science/article/pii/S2213158215001072/pdfft?md5=850ee09b40e3f024731a495688d08f9d&pid=1-s2.0-S2213158215001072-main.pdfCitation Count: 23
-
OPENTitle: Genetic influences on cognition in progressive supranuclear palsyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 12Start Page: 1764End Page: 1771Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27196Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5818145Citation Count: 9
-
OPENTitle: Pedestrian safety in patients with Parkinson's disease: A case‐control studyJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 12Start Page: 1748End Page: 1755Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27124Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5732050Citation Count: 9
-
OPENTitle: Clinical Features of Patients with Concomitant Parkinson's Disease and Progressive Supranuclear Palsy PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 2Issue #: 1Start Page: 33End Page: 38Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.12104Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.12104Citation Count: 4
- Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degeneration2016OPENTitle: Study of LRRK2 variation in tauopathy: Progressive supranuclear palsy and corticobasal degenerationJournal Name: Movement DisordersPublisher: WileyVol: 32Issue #: 1Start Page: 115End Page: 123Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.26815Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5269612Citation Count: 59
-
OPENTitle: Generation of SNCA Cell Models Using Zinc Finger Nuclease (ZFN) Technology for Efficient High-Throughput Drug ScreeningJournal Name: PLOS ONEPublisher: Public Library of Science (PLoS)Vol: 10Issue #: 8Start Page: e0136930End Page: e0136930Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0136930Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0136930&type=printableCitation Count: 21
-
OPENTitle: Conformational heterogeneity of the Roc domains in C. tepidum Roc–COR and implications for human LRRK2 Parkinson mutationsJournal Name: Bioscience ReportsPublisher: Portland Press Ltd.Vol: 35Issue #: 5Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1042/bsr20150128Best OA location URL: https://portlandpress.com/bioscirep/article-pdf/35/5/e00254/477473/bsr035e254.pdfCitation Count: 27
-
OPENTitle: Elevated Serum Pesticide Levels and Risk of Parkinson DiseaseJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 66Issue #: 7Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2009.89Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3383784Citation Count: 131
-
OPENTitle: Neuropathological comparisons of amnestic and nonamnestic mild cognitive impairmentJournal Name: BMC NeurologyPublisher: Springer Science and Business Media LLCVol: 15Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1186/s12883-015-0403-4Best OA location URL: https://bmcneurol.biomedcentral.com/counter/pdf/10.1186/s12883-015-0403-4Citation Count: 52
- Roles of Education and IQ in Cognitive Reserve in Parkinson’s Disease-Mild Cognitive Impairment2012OPENTitle: Roles of Education and IQ in Cognitive Reserve in Parkinson’s Disease-Mild Cognitive ImpairmentJournal Name: Dementia and Geriatric Cognitive Disorders ExtraPublisher: S. Karger AGVol: 2Issue #: 1Start Page: 343End Page: 352Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1159/000341782Best OA location URL: https://escholarship.org/uc/item/57s336shCitation Count: 41
-
OPENTitle: A Neurodegenerative Vascular Burden Index and the Impact on CognitionJournal Name: Frontiers in Aging NeurosciencePublisher: Frontiers Media SAVol: 6Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3389/fnagi.2014.00161Best OA location URL: https://pub.dzne.de/record/137515Citation Count: 15
-
OPENTitle: S-Nitrosylation of ApoE in Alzheimer’s DiseaseJournal Name: BiochemistryPublisher: American Chemical Society (ACS)Vol: 50Issue #: 17Start Page: 3405End Page: 3407Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/bi200266vBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3082618Citation Count: 39
-
OPENTitle: BACE1 Levels by APOE Genotype in Non-Demented and Alzheimer’s Post-Mortem BrainsJournal Name: Current Alzheimer ResearchPublisher: Bentham Science Publishers Ltd.Vol: 10Issue #: 3Start Page: 309End Page: 315Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.2174/1567205011310030010Best OA location URL: http://www.eurekaselect.com/article/50383Citation Count: 13
-
OPENTitle: Ephrin‐A5 regulates the formation of the ascending midbrain dopaminergic pathwaysJournal Name: Developmental NeurobiologyPublisher: WileyVol: 69Issue #: 1Start Page: 36End Page: 46Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/dneu.20685Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4026181Citation Count: 40
- Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse Model2013OPENTitle: Bee Venom and Its Component Apamin as Neuroprotective Agents in a Parkinson Disease Mouse ModelJournal Name: PLoS ONEPublisher: Public Library of Science (PLoS)Vol: 8Issue #: 4Start Page: e61700End Page: e61700Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1371/journal.pone.0061700Best OA location URL: https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0061700&type=printableCitation Count: 117
-
OPENTitle: Is PARKIN parkinsonism a cancer predisposition syndrome?Journal Name: Neurology GeneticsPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 1Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1212/nxg.0000000000000031Best OA location URL: https://ng.neurology.org/content/nng/1/4/e31.full.pdfCitation Count: 4
-
OPENTitle: Hemispheric asymmetry of electroencephalography-based functional brain networksJournal Name: NeuroReportPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 25Issue #: 16Start Page: 1266End Page: 1271Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1097/wnr.0000000000000256Citation Count: 10
-
OPENTitle: Relationship Between CSF Biomarkers of Alzheimer's Disease and Rates of Regional Cortical Thinning in ADNI DataJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 26Issue #: s3Start Page: 77End Page: 90Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2011-0006Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4587763Citation Count: 50
-
OPENTitle: Positive Florbetapir PET Amyloid Imaging in a Subject with Frequent Cortical Neuritic Plaques and Frontotemporal Lobar Degeneration with TDP43-Positive InclusionsJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 42Issue #: 3Start Page: 813End Page: 821Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-140162Best OA location URL: http://doi.org/10.3233/JAD-140162Citation Count: 23
-
OPENTitle: TDP-43 deposition in prospectively followed, cognitively normal elderly individuals: correlation with argyrophilic grains but not other concomitant pathologiesJournal Name: Acta NeuropathologicaPublisher: Springer Science and Business Media LLCVol: 126Issue #: 1Start Page: 51End Page: 57Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s00401-013-1110-0Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3691299Citation Count: 90
-
OPENTitle: Alzheimer Research Forum Live Discussion: Mice on Trial? Issues in the Design of Drug StudiesJournal Name: Journal of Alzheimer's DiseasePublisher: SAGE PublicationsVol: 16Issue #: 1Start Page: 197End Page: 205Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jad-2009-0961Best OA location URL: https://content.iospress.com:443/download/journal-of-alzheimers-disease/jad00961?id=journal-of-alzheimers-disease%2Fjad00961Citation Count: 1
-
OPENTitle: Bacillus Calmette-Guerin vaccine-mediated neuroprotection is associated with regulatory T-cell induction in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine mouse model of Parkinson's diseaseJournal Name: Journal of Neuroscience ResearchPublisher: WileyVol: 91Issue #: 10Start Page: 1292End Page: 1302Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/jnr.23253Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5800426Citation Count: 58
-
OPENTitle: Parkin mediates the degradation‐independent ubiquitination of Hsp70Journal Name: Journal of NeurochemistryPublisher: WileyVol: 105Issue #: 5Start Page: 1806End Page: 1819Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2008.05261.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4432938Citation Count: 99
-
OPENTitle: Toxic Oligomeric Alpha-Synuclein Variants Present in Human Parkinson’s Disease Brains Are Differentially Generated in Mammalian Cell ModelsJournal Name: BiomoleculesPublisher: MDPI AGVol: 5Issue #: 3Start Page: 1634End Page: 1651Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.3390/biom5031634Best OA location URL: https://www.mdpi.com/2218-273X/5/3/1634/pdf?version=1437555461Citation Count: 37
-
OPENTitle: Impact of belief in neuroprotection on therapeutic intervention in Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 8Start Page: 1082End Page: 1086Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22997Best OA location URL: https://europepmc.org/articles/pmc2891220?pdf=renderCitation Count: 1
-
OPENTitle: FGF20 and Parkinson's disease: No evidence of association or pathogenicity via α‐synuclein expressionJournal Name: Movement DisordersPublisher: WileyVol: 24Issue #: 3Start Page: 455End Page: 459Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.22442Best OA location URL: http://doi.org/10.1002/mds.22442Citation Count: 44
-
OPENTitle: Par3 and aPKC regulate BACE1 endosome-to-TGN trafficking through PACS1Journal Name: Neurobiology of AgingPublisher: Elsevier BVVol: 60Issue #:Start Page: 129End Page: 140Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neurobiolaging.2017.08.024Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5653456Citation Count: 24
-
OPENTitle: Isolation and characterization of antibody fragments selective for specific protein morphologies from nanogram antigen samplesJournal Name: Biotechnology ProgressPublisher: WileyVol: 29Issue #: 2Start Page: 463End Page: 471Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/btpr.1698Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3618510Citation Count: 24
-
OPENTitle: Activation of the mGlu1 metabotropic glutamate receptor has antipsychotic-like effects and is required for efficacy of M4 muscarinic receptor allosteric modulatorsJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 25Issue #: 11Start Page: 2786End Page: 2799Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-018-0206-2Best OA location URL: https://www.nature.com/articles/s41380-018-0206-2.pdfCitation Count: 46
-
OPENTitle: Stress and the risk of multiple sclerosisJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 76Issue #: 22Start Page: 1866End Page: 1871Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e31821d74c5Best OA location URL: https://n.neurology.org/content/neurology/76/22/1866.full.pdfCitation Count: 68
-
OPENTitle: Cognitive performance of GBA mutation carriers with early-onset PDJournal Name: NeurologyPublisher: Ovid Technologies (Wolters Kluwer Health)Vol: 78Issue #: 18Start Page: 1434End Page: 1440Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1212/wnl.0b013e318253d54bBest OA location URL: https://n.neurology.org/content/neurology/78/18/1434.full.pdfCitation Count: 258
-
OPENTitle: Autophosphorylation in the Leucine-Rich Repeat Kinase 2 (LRRK2) GTPase Domain Modifies Kinase and GTP-Binding ActivitiesJournal Name: Journal of Molecular BiologyPublisher: Elsevier BVVol: 412Issue #: 1Start Page: 94End Page: 110Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.jmb.2011.07.033Citation Count: 123
-
OPENTitle: Calcium channel blocker use and risk of Parkinson's diseaseJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 12Start Page: 1818End Page: 1822Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23191Citation Count: 42
-
OPENTitle: Clinical expression of LRRK2 G2019S mutations in the elderlyJournal Name: Movement DisordersPublisher: WileyVol: 25Issue #: 15Start Page: 2571End Page: 2576Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.23330Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2978804Citation Count: 23
- Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology2017OPENTitle: Dysregulation of 14‐3‐3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathologyJournal Name: Annals of Clinical and Translational NeurologyPublisher: WileyVol: 4Issue #: 7Start Page: 466End Page: 477Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1002/acn3.421Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/acn3.421Citation Count: 38
-
OPENTitle: Pathogenic Parkinson’s disease mutations across the functional domains of LRRK2 alter the autophagic/lysosomal response to starvationJournal Name: Biochemical and Biophysical Research CommunicationsPublisher: Elsevier BVVol: 441Issue #: 4Start Page: 862End Page: 866Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.bbrc.2013.10.159Best OA location URL: https://doi.org/10.1016/j.bbrc.2013.10.159Citation Count: 82
-
OPENTitle: The synaptic impact of the host immune response in a parkinsonian allograft rat model: Influence on graft-derived aberrant behaviorsJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 32Issue #: 2Start Page: 229End Page: 242Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.06.018Best OA location URL: http://doi.org/10.1016/j.nbd.2008.06.018Citation Count: 62
-
OPENTitle: Nociceptin/orphanin FQ receptor blockade attenuates MPTP-induced parkinsonismJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 30Issue #: 3Start Page: 430End Page: 438Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2008.02.011Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/2605654Citation Count: 63
- Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRI2017OPENTitle: Preparation of biogenic gas vesicle nanostructures for use as contrast agents for ultrasound and MRIJournal Name: Nature ProtocolsPublisher: Springer Science and Business Media LLCVol: 12Issue #: 10Start Page: 2050End Page: 2080Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/nprot.2017.081Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6185898Citation Count: 143
-
OPENTitle: Genetic and Clinical Features of Progranulin-Associated Frontotemporal Lobar DegenerationJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 68Issue #: 4Start Page: 488End Page: 488Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.53Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3160280Citation Count: 115
-
OPENTitle: Reduced Uptake of FDOPA PET in End-stage Liver Disease With Elevated Manganese LevelsJournal Name: Archives of NeurologyPublisher: American Medical Association (AMA)Vol: 69Issue #: 3Start Page: 394End Page: 394Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1001/archneurol.2011.771Citation Count: 26
-
OPENTitle: Distinct clinical and neuropathological features of G51D SNCA mutation cases compared with SNCA duplication and H50Q mutationJournal Name: Molecular NeurodegenerationPublisher: Springer Science and Business Media LLCVol: 10Issue #: 1Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by, cc-byDOI - Digital Object Identifier: 10.1186/s13024-015-0038-3Best OA location URL: https://molecularneurodegeneration.biomedcentral.com/counter/pdf/10.1186/s13024-015-0038-3Citation Count: 110
-
OPENTitle: Testing NF-κB-based Therapy in Hemiparkinsonian MonkeysJournal Name: Journal of Neuroimmune PharmacologyPublisher: Springer Science and Business Media LLCVol: 7Issue #: 3Start Page: 544End Page: 556Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1007/s11481-012-9377-9Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3419771Citation Count: 40
-
OPENTitle: RGS10 exerts a neuroprotective role through the PKA/c‐AMP response‐element (CREB) pathway in dopaminergic neuron‐like cellsJournal Name: Journal of NeurochemistryPublisher: WileyVol: 122Issue #: 2Start Page: 333End Page: 343Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/j.1471-4159.2012.07780.xBest OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/3435458Citation Count: 38
- Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.2006OPENTitle: Complement activation in the Parkinson's disease substantia nigra: an immunocytochemical study.Journal Name: Journal of NeuroinflammationPublisher: Springer Science and Business Media LLCVol: 3Issue #: 1Start Page: 29End Page: 29Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1186/1742-2094-3-29Best OA location URL: https://jneuroinflammation.biomedcentral.com/counter/pdf/10.1186/1742-2094-3-29Citation Count: 138
-
OPENTitle: Transgenic mice expressing S129 phosphorylation mutations in α-synucleinJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 563Issue #:Start Page: 96End Page: 100Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2014.01.033Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4059511Citation Count: 14
-
OPENTitle: Leucine-Rich Repeat Kinase 2 Binds to Neuronal Vesicles through Protein Interactions Mediated by Its C-Terminal WD40 DomainJournal Name: Molecular and Cellular BiologyPublisher: Informa UK LimitedVol: 34Issue #: 12Start Page: 2147End Page: 2161Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1128/mcb.00914-13Best OA location URL: https://mcb.asm.org/content/mcb/34/12/2147.full.pdfCitation Count: 99
-
OPENTitle: Identification of a highly neurotoxic α-synuclein species inducing mitochondrial damage and mitophagy in Parkinson’s diseaseJournal Name: Proceedings of the National Academy of SciencesPublisher: Proceedings of the National Academy of SciencesVol: 115Issue #: 11Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1073/pnas.1713849115Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5856519Citation Count: 197
-
OPENTitle: Epidemiology of Parkinson's diseaseJournal Name: Handbook of Clinical NeurologyPublisher: ElsevierVol:Issue #:Start Page: 129End Page: 151Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s0072-9752(07)83006-5Citation Count: 131
-
OPENTitle: Differential LRRK2 expression in the cortex, striatum, and substantia nigra in transgenic and nontransgenic rodentsJournal Name: Journal of Comparative NeurologyPublisher: WileyVol: 522Issue #: 11Start Page: 2465End Page: 2480Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/cne.23583Best OA location URL: http://doi.org/10.1002/cne.23583Citation Count: 127